Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Discovery & Development Drug Discovery

Bacterial Boost

Can microbes enhance the efficacy of immunotherapy?

Maryam Mahdi | | Quick Read

Why don’t immunotherapies work for everyone? The answer isn’t entirely clear – but new research published in Science sheds some light (1). According to Lukas Mager, a senior postdoctoral researcher at the University of Calgary and first author of the paper, specific bacteria in the gut microbiome play a significant role in the success of immunotherapies in treating certain cancers.

Read the full article now

Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE!

Login

Forgot your password?

Or register now - it’s free!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

When you click “Register” we will email you a link, which you must click to verify the email address above and activate your account. If you do not receive this email, please contact us at [email protected].

Discovery & Development Drug Discovery

About the Author

Maryam Mahdi

Associate Editor

After finishing my degree, I envisioned a career in science communications. However, life took an unexpected turn and I ended up teaching abroad. Though the experience was amazing and I learned a great deal from it, I jumped at the opportunity to work for Texere. I'm excited to see where this new journey takes me!

Related Webinars

Discovery & Development COVID-19

Post-Pandemic Planning: What Will Change in the Clinical Supply Chain?

| Sponsored by Thermo Fisher Scientific

Discovery & Development COVID-19

Post-Pandemic Planning: What Will Change in Early-Phase Drug Development?

| Sponsored by Thermo Fisher Scientific

Discovery & Development Clinical Trials

Double blind. Zero bias.

| Sponsored by Capsugel Lonza

Most Popular

1. Business & Regulation Business Practice

Crafting a Culture of Excellence

| Maryam Mahdi

2. Business & Regulation Business Practice

Stemming the Brain Drain

| Kelly Chibale

3. Business & Regulation Business Practice

Building a Beautiful Biotech

| James Strachan

4. Manufacture Formulation

The Rise of Lipid Nanoparticles

| Rahul Keswani, Benjamin King

5. Discovery & Development Drug Delivery

Melt in the Mouth

| Elizabeth Hickman

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

December Issue of The Medicine Maker